Skip to Content

LUNG CANCER PANEL 3 [EGFR, ALK1, ROS1, MET] (SDL11825)

https://www.scanlabglobal.com/web/image/product.template/6214/image_1920?unique=18393fc
Tests EGFR, ALK, ROS1, MET in tissue for advanced NSCLC. Mutations guide TKIs or MET inhibitors like capmatinib for lung cancer.

4,200.00 AED 4200.0 AED 4,200.00 AED

4,200.00 AED

Not Available For Sale

This combination does not exist.